CRIMALDDI

"Coordination, rationalisation and integration of antimalarial drug discovery initiatives"

 Coordinatore LIVERPOOL SCHOOL OF TROPICAL MEDICINE 

 Organization address address: Pembroke Place
city: LIVERPOOL
postcode: L35QA

contact info
Titolo: Mr.
Nome: Robert Einion
Cognome: Holland
Email: send email
Telefono: +44 151 705 3167
Fax: +44 151 705 3363

 Nazionalità Coordinatore United Kingdom [UK]
 Totale costo 560˙747 €
 EC contributo 500˙000 €
 Programma FP7-HEALTH
Specific Programme "Cooperation": Health
 Code Call FP7-HEALTH-2007-B
 Funding Scheme CSA-CA
 Anno di inizio 2009
 Periodo (anno-mese-giorno) 2009-02-01   -   2011-06-30

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    LIVERPOOL SCHOOL OF TROPICAL MEDICINE

 Organization address address: Pembroke Place
city: LIVERPOOL
postcode: L35QA

contact info
Titolo: Mr.
Nome: Robert Einion
Cognome: Holland
Email: send email
Telefono: +44 151 705 3167
Fax: +44 151 705 3363

UK (LIVERPOOL) coordinator 292˙100.00
2    Medicines for Malaria Venture

 Organization address address: ROUTE DE PRE BOIS 20
city: GENEVE
postcode: CH1215

contact info
Titolo: Mr.
Nome: Peter
Cognome: Potter-Lesage
Email: send email
Telefono: -4840
Fax: -4841

CH (GENEVE) participant 58˙650.00
3    WORLD HEALTH ORGANIZATION.

 Organization address address: Avenue Appia 20
city: GENEVE
postcode: 1211

contact info
Titolo: Dr.
Nome: Solomon
Cognome: Nwaka
Email: send email
Telefono: +41 22 791 3767
Fax: +41 22 791 4854

CH (GENEVE) participant 58˙650.00
4    UNIVERSITY OF CAPE TOWN

 Organization address address: PRIVATE BAG X3
city: RONDEBOSCH
postcode: 7701

contact info
Titolo: Mr.
Nome: Roger
Cognome: Wallace
Email: send email
Telefono: 27216504718
Fax: 27216505778

ZA (RONDEBOSCH) participant 30˙000.00
5    CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

 Organization address address: Rue Michel -Ange 3
city: PARIS
postcode: 75794

contact info
Titolo: Mr.
Nome: Jean-Michel
Cognome: Portefaix
Email: send email
Telefono: -67613506
Fax: -67043207

FR (PARIS) participant 12˙650.00
6    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)

 Organization address address: 101 Rue de Tolbiac
city: PARIS
postcode: 75654

contact info
Titolo: Ms.
Nome: Rofigua
Cognome: Hakem
Email: send email
Telefono: +33 3 20 29 93 73
Fax: +33 3 20 49 01 38

FR (PARIS) participant 12˙650.00
7    UNIVERSITA DEGLI STUDI DI MILANO

 Organization address address: Via Festa Del Perdono 7
city: MILANO
postcode: 20122

contact info
Titolo: Ms.
Nome: Luciana
Cognome: Lucchini
Email: send email
Telefono: +39 02 5031 5060
Fax: +39 02 5031 5068

IT (MILANO) participant 12˙650.00
8    UNIVERSITAETSKLINIKUM HEIDELBERG

 Organization address address: IM NEUENHEIMER FELD 672
city: HEIDELBERG
postcode: 69120

contact info
Titolo: Mr.
Nome: Thorsten
Cognome: Brietz
Email: send email
Telefono: -573258
Fax: -571632

DE (HEIDELBERG) participant 12˙650.00
9    UNIVERSITY OF BUEA

 Organization address address: PO BOX 63
city: BUEA SOUTHWEST REGION

contact info
Titolo: Ms.
Nome: Lydia
Cognome: Egbe
Email: send email
Telefono: (237) 33 32 21 34
Fax: (237) 33 32 22 72

CM (BUEA SOUTHWEST REGION) participant 10˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

ordinate    malaria    co    antimalarial    drug    discovery   

 Obiettivo del progetto (Objective)

'Antimalarial drug discovery and development initiatives globally are fragmented and uncoordinated. We have brought together key organisations including MMV, WHO and AntiMal, an EU-funded FP6 Integrated Project represented by its coordinating institution and a number of academic malaria researchers, to resolve this problem through a logical series of meetings, conferences, workshops and dissemination strategies. The Gates Foundation will be involved as an invited participant. The action will co-ordinate leading European malaria research initiatives in antimalarial drug discovery and development, co-ordinate the European effort with international initiatives, engage industry and provide guidance on standardisation of core requirements of regulatory drug development. This will contribute towards generating global priorities and prepare the European antimalarial research agenda for the next decade.'

Altri progetti dello stesso programma (FP7-HEALTH)

UROMOL (2008)

Prediction of bladder cancer disease course using risk scores that combine molecular and clinical risk factors

Read More  

CHILD-INNOVAC (2008)

NASAL VACCINATION AGAINST RESPIRATORY INFECTIONS IN YOUNG CHILDREN

Read More  

NRT (2012)

Phase II clinical trial of PDGF-BB for the neurological regeneration and recovery in Parkinson´s disease

Read More